130 related articles for article (PubMed ID: 10761329)
21. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.
Nakanishi Y; Kodama J; Yoshinouchi M; Tokumo K; Kamimura S; Okuda H; Kudo T
Int J Gynecol Pathol; 1997 Jul; 16(3):256-62. PubMed ID: 9421092
[TBL] [Abstract][Full Text] [Related]
22. On the pathogenesis of sclerosing stromal tumor of the ovary: a neoplasm in transition.
Roth LM; Gaba AR; Cheng L
Int J Gynecol Pathol; 2014 Sep; 33(5):449-62. PubMed ID: 25083960
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
24. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
25. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Jan; 84(1):47-52. PubMed ID: 11748975
[TBL] [Abstract][Full Text] [Related]
27. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma.
Nakayama K; Kanzaki A; Hata K; Katabuchi H; Okamura H; Miyazaki K; Fukumoto M; Takebayashi Y
Cancer Lett; 2002 Feb; 176(2):215-23. PubMed ID: 11804750
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.
Akutagawa N; Nishikawa A; Iwasaki M; Fujimoto T; Teramoto M; Kitajima Y; Endo T; Shibuya M; Kudo R
Jpn J Cancer Res; 2002 Jun; 93(6):644-51. PubMed ID: 12079512
[TBL] [Abstract][Full Text] [Related]
30. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.
Kang SM; Maeda K; Onoda N; Chung YS; Nakata B; Nishiguchi Y; Sowa M
Int J Cancer; 1997 Oct; 74(5):502-7. PubMed ID: 9355971
[TBL] [Abstract][Full Text] [Related]
31. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
32. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.
Maeda K; Kang SM; Onoda N; Ogawa M; Sawada T; Nakata B; Kato Y; Chung YS; Sowa M
Oncology; 1998; 55(6):594-9. PubMed ID: 9778629
[TBL] [Abstract][Full Text] [Related]
34. [Sclerosing stromal tumor--a rare benign ovarian neoplasm].
Tomsová M; Krepinská E; Spacek J
Ceska Gynekol; 2008 Jun; 73(3):188-91. PubMed ID: 18646673
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
36. Sclerosing stromal tumour of the ovary: two case reports.
Limaiem F; Boudabous E; Ben Slama S; Chelly B; Lahmar A; Bouraoui S; Gara F; Mzabi S
Pathologica; 2013 Apr; 105(2):62-5. PubMed ID: 23951586
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of expression of vascular endothelial growth factor and matrix matalloproteinase-2 to invasion of ovarian tumor cells in vitro].
Zhang AL; Wang SX; Lu YP; Li J; Wang CY; Ma D
Ai Zheng; 2002 Mar; 21(3):263-6. PubMed ID: 12451991
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors.
Garzetti GG; Ciavattini A; Lucarini G; Pugnaloni A; De Nictolis M; Amati S; Romanini C; Biagini G
Cancer; 1999 May; 85(10):2219-25. PubMed ID: 10326701
[TBL] [Abstract][Full Text] [Related]
39. Calcifying sclerosing tumor of the ovary: a late stage of sclerosing stromal tumor?
Zámecník M
Cesk Patol; 2002 Jul; 38(3):121-4. PubMed ID: 12325477
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
